Table 1.
Author | Year | Country | Gender, M/F | Age, years (mean age ± SD) (range age) | Biliary diseases | Samples | Specific primers | Helicobacter species | Cases | Controls | Nos. |
---|---|---|---|---|---|---|---|---|---|---|---|
Bahri Abayli et al. | 2005 | Turkey | 28/49 | M: 50 (25–73) F: 54 (24–80) |
Cholelithiasis, cholecystitis | Gallstone | 16S rRNA gene | H. pylori | 77 | 20 | 6 |
Cíntia Presser Silva et al. | 2003 | Brazil | 27/37 | Cases: 51.5 ± 16.4 (21–80); controls: 38.3 ± 17.4 (18–70) | Cholelithiasis | Bile, gallbladder | 16S rRNA gene | H. pylori | 46 | 18 | 7 |
Isaeva Aeva et al. | 2018 | Russia | 37/77 | Cases: cholecystitis 42.6 ± 4.8, cholelithiasis 57.1 ± 3.6; controls: 42.9 ± 3.4 | Cholelithiasis, cholecystitis | Bile ducts, gallbladder | Urease C gene | H. pylori | 84 | 30 | 6 |
Griniatsos et al. | 2009 | Greece | 22/67 | 63 (51–73) | Cholelithiasis | Gallbladder | 16S rRNA gene | H. pylori | 89 | 42 | 7 |
Kenichi Harada et al. | 2001 | Japan | None | None | Cholelithiasis | Bile | 16S rRNA gene | H. pylori | 39 | 9 | 6 |
Milutin Bulajic et al. | 2002 | Serbia | 32/40 | 56.7 ± 16.45 | Cholelithiasis | Bile | Urease A gene | H. pylori | 65 | 7 | 6 |
Milutin Bulajic et al. | 2002 | Serbia | 42/47 | None | Cholelithiasis | Bile | Urease A gene, 16S rDNA gene | H. pylori | 63 | 11 | 7 |
Mohammad Yousuf Dar et al. | 2016 | India | 29/46 | Cases: 40.5 ± 10.85 (18–75); controls: 37.3 ± 9.6 (18–54) | Cholelithiasis | Bile | 26 kDa surface antigen | H. pylori | 50 | 25 | 6 |
Norio Matsukura et al. | 2002 | Japan, Thailand | 30/15 | 65.2 (24–83) | Cholelithiasis, cholecystitis | Bile | 16S rRNA gene | H. bilis | 42 | 14 | 7 |
Farshad et al. | 2004 | Iran | None | Cases: 18–70; controls: 20–67 | Cholelithiasis, cholecystitis | Bile | 16S rRNA gene, isocitrate dehydrogenase gene | H. pylori | 33 | 40 | 6 |
Somayeh Janani Sherafat et al. | 2012 | Iran | None | None | Cholelithiasis | Bile | 16S rRNA gene | H. pylori | 74 | 13 | 6 |
Takashi Kobayashi et al. | 2005 | Japan | None | None | Cholelithiasis | Bile | 16S rRNA gene | H. pylori | 30 | 21 | 7 |
Toshihide Hamada et al. | 2009 | Japan | 43/49 | Cases: 61.2 controls: 69.2 |
Cholelithiasis, cholecystitis | Bile | 16S rRNA gene | H. hepaticus | 60 | 32 | 6 |
Bohr et al. | 2007 | German | None | None | Cholelithiasis | Gallbladder | 16S rRNA gene | H. ganmani | 57 | 22 | 7 |
Virinder Kumar Bansal et al. | 2012 | India | None | None | Cholelithiasis, cholecystitis | Bile | Urease A gene | H. pylori | 49 | 12 | 7 |
Chen et al. | 2003 | New Zealand | 39/68 | Cases: symptomatic gallstones 47.4 (23.3–79.9); asymptomatic gallstones 50.6 (35.7–66.0); controls: 58.7 (23.2–74.4) | Cholelithiasis | Gallbladder | 16S rRNA gene | H. pylori | 70 | 37 | 6 |
Roosendaal et al. | 2002 | Netherlands | None | 73 (42–85) | Cholelithiasis | Bile | 16S rDNA gene | H. pylori | 28 | 3 | 7 |
Seyed Masih Fatemi et al. | 2017 | Iran | 58/19 | 46.85 ± 14.53 | Cholelithiasis, cholecystitis | Bile | Hsp60 gene, 16S rRNA gene | H. pylori, H. bilis | 52 | 25 | 7 |
Karagin et al. | 2010 | Sweden | 79/113 | Cases: 48 (20–84); controls: 58 (11–85) | Cholecystitis | Gallbladder | 16S rRNA gene | H. pylori, H. pullorum | 100 | 102 | 6 |
Yakoob et al. | 2011 | Pakistan | 43/101 | 49 ± 14 (18–84) | Cholecystitis, cholelithiasis | Bile, gallbladder | 16S rRNA gene | H. pylori | 89 | 55 | 6 |
M, male; F, female; NOS, Newcastle–Ottawa scale assessment.